Page 44 - AN-2-3
P. 44

Advanced Neurology                                                   Multiple sclerosis: Immunopathogenesis



               systemic disease in the evaluation of suspected multiple   to relapsing remitting multiple sclerosis: A  retrospective
               sclerosis:  A  single-center  observational  study.  Mult Scler   comorbidity cohort study. Eur Neurol, 83: 287–292.
               Relat Disord, 69: 104443.
                                                                  https://doi.org/10.1159/000507547
               https://doi.org/10.1016/j.msard.2022.104443
                                                               75.  Abri Aghdam K, Aghajani A, Kanani F,  et al., 2021, A
            65.  Berer K, Gerdes LA, Cekanaviciute E,  et al., 2017, Gut   novel decision tree approach to predict the probability of
               microbiota from multiple sclerosis patients enables   conversion to multiple sclerosis in Iranian patients with
               spontaneous autoimmune encephalomyelitis in mice. Proc   optic neuritis. Mult Scler Relat Disord, 47: 102658.
               Natl Acad Sci U S A, 114: 10719–10724.
                                                                  https://doi.org/10.1016/j.msard.2020.102658
                https://doi.org/10.1073/pnas.1711233114
                                                               76.  Kenney R, Liu M, Patil S, et al., 2021, Long-term outcomes
            66.  Jangi S, Gandhi R, Cox LM, et al., 2016, Alterations of the   in patients presenting with optic neuritis: Analyses of the
               human gut microbiome in multiple sclerosis. Nat Commun,   MSBase registry. J Neurol Sci, 430: 118067.
               7: 12015.
                                                                  https://doi.org/10.1016/j.jns.2021.118067
               https://doi.org/10.1038/ncomms12015
                                                               77.  Gu W, Tagg NT, Panchal NL,  et al., 2021, Incidence of
            67.  Cekanaviciute E, Yoo BB, Runia TF, et al., 2017, Gut bacteria   optic neuritis and the associated risk of multiple sclerosis
               from multiple sclerosis patients modulate human T cells and   for service members of U.S. Armed forces. Mil Med, 188:
               exacerbate symptoms in mouse models. Proc Natl Acad Sci   usab352.
               U S A, 114: 10713–10718.
                                                                  https://doi.org/10.1093/milmed/usab352
               https://doi.org/10.1073/pnas.1711235114
                                                               78.  Ysrraelit MC, Correale J, 2019, Impact of sex hormones
            68.  Reynders T, Devolder L, Valles-Colomer M,  et al., 2020,   on immune function and multiple sclerosis development.
               Gut microbiome variation is associated to multiple sclerosis   Immunology, 156: 9–22.
               phenotypic subtypes. Ann Clin Transl Neurol, 7: 406–419.
                                                                  https://doi.org/10.1111/imm.13004
               https://doi.org/10.1002/acn3.51004
                                                               79.  Lee JY, Han J, Yang M,  et al., 2020, Population-based
            69.  Kappos L, Wolinsky JS, Giovannoni G,  et al., 2020,   incidence of pediatric and adult optic neuritis and the risk
               Contribution of relapse-independent progression vs   of multiple sclerosis. Ophthalmology, 127: 417–425.
               relapse-associated worsening to overall confirmed disability
               accumulation in typical relapsing multiple sclerosis in      https://doi.org/10.1016/j.ophtha.2019.09.032
               a pooled analysis of 2 randomized clinical trials.  JAMA   80.  Pihl-Jensen G, Wanscher B, Frederiksen JL, 2021, Predictive
               Neurol, 77: 1132–1140.                             value of optical coherence tomography, multifocal visual
               https://doi.org/10.1001/jamaneurol.2020.1568       evoked potentials, and full-field visual evoked potentials of
                                                                  the fellow, non-symptomatic eye for subsequent multiple
            70.  Giovannoni G, Popescu V, Wuerfel J,  et al., 2022,   sclerosis development in patients with acute optic neuritis.
               Smouldering multiple sclerosis: The “real MS”. Ther Adv   Mult Scler, 27: 391–400.
               Neurol Disord, 15: 17562864211066751.
                                                                  https://doi.org/10.1177/1352458520917924
               https://doi.orr/10.1177/17562864211066751
                                                               81.  Sorensen PS, Sellebjerg F, Hartung HP,  et al., 2020, The
            71.  Luchetti  S, Fransen  NL,  Van  Eden  CG,  et al.,  2018,   apparently milder course of multiple sclerosis: Changes in
               Progressive  multiple  sclerosis  patients  show  substantial   the diagnostic criteria, therapy and natural history. Brain,
               lesion activity that correlates with clinical disease severity   143: 2637–2652.
               and sex: A  retrospective autopsy cohort analysis.  Acta
               Neuropathol, 135: 511–528.                         https://doi.org/10.1093/brain/awaa145
               https://doi.org/10.1007/s00401-018-1818-y       82.  Sati P, Oh J, Constable RT,  et al., 2016, The central vein
                                                                  sign and its clinical evaluation for the diagnosis of multiple
            72.  Sastre-Garriga J, Pareto D, Rovira À, 2017, Brain atrophy in   sclerosis: A consensus statement from the North American
               multiple sclerosis: Clinical relevance and technical aspects.   imaging in multiple sclerosis cooperative. Nat Rev Neurol,
               Neuroimaging Clin N Am, 27: 289–300.               12: 714–722.
               https://doi.org/10.1016/j.nic.2017.01.002
                                                                  https://doi.org/10.1038/nrneurol.2016.166
            73.  Tintore M, Vidal-Jordana A, Sastre-Garriga J, 2019,   83.  Van der Vuurst de Vries RM, Mescheriakova JY, Samijn JP,
               Treatment of multiple sclerosis-success from bench to   et al.,  2018,  Application  of  the  2017  revised  McDonald
               bedside. Nat Rev Neurol, 15: 53–58.                criteria for Multiple Sclerosis to patients with a typical
               https://doi.org/10.1038/s41582-018-0082-z          clinically isolated syndrome. JAMA Neurol, 75: 1392–1398.
            74.  Koseoglu M, Tutuncu M, 2020, Conversion of optic neuritis      https://doi.org/10.1001/jamaneurol.2018.2160


            Volume 2 Issue 3 (2023)                         13                        https://doi.org/10.36922/an.1319
   39   40   41   42   43   44   45   46   47   48   49